Table 3.

FOXD3 expression and clinicopathological features of human gliomas

Characteristics	Patients, n	FOXD3 expression, n		P value
		High	Low
Age (years)
<50	19	7	12	0.434
≥50	25	11	14
Gender
Male	28	11	17	0.509
Female	16	7	9
WHO grade
I-II	13	2	11	0.026
III-IV	31	16	15
Tumor size (cm)
<5	17	5	12	0.18
≥5	27	13	14
KPS
<70	4	2	2	0.545
≥70	40	16	24

KPS, karnofsky performance score.